Cargando…

Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench

SIMPLE SUMMARY: To find the cause of our current failures in drug development and data reproducibility, we may need to search no further than the basic premises of translational research. To enhance cancer research and cancer care, we need to be diligent in the proper application of the scientific m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Shi-Ming, Singh, Sunny R., Arnaoutakis, Konstantinos, Malapati, Sindhu, Bhatti, Sajjad A., Joon, Aron Y., Atiq, Omar T., Pisters, Louis L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321703/
https://www.ncbi.nlm.nih.gov/pubmed/35884406
http://dx.doi.org/10.3390/cancers14143345
_version_ 1784756113020813312
author Tu, Shi-Ming
Singh, Sunny R.
Arnaoutakis, Konstantinos
Malapati, Sindhu
Bhatti, Sajjad A.
Joon, Aron Y.
Atiq, Omar T.
Pisters, Louis L.
author_facet Tu, Shi-Ming
Singh, Sunny R.
Arnaoutakis, Konstantinos
Malapati, Sindhu
Bhatti, Sajjad A.
Joon, Aron Y.
Atiq, Omar T.
Pisters, Louis L.
author_sort Tu, Shi-Ming
collection PubMed
description SIMPLE SUMMARY: To find the cause of our current failures in drug development and data reproducibility, we may need to search no further than the basic premises of translational research. To enhance cancer research and cancer care, we need to be diligent in the proper application of the scientific method. We postulate that a stem cell theory of cancer embraces genomic medicine and empowers integrated medicine. It alludes to a unified theory of cancer that may advance cancer research by emending translational research and enforcing the scientific method. It may enhance patient care by enabling targeted therapy and employing multimodal therapy, so that we treat the whole cancer and heal the whole patient. ABSTRACT: A stem cell theory of cancer considers genetic makeup in the proper cellular context. It is a unified theory of cancer that unites the genome with the epigenome, links the intracellular with the extracellular, and connects the cellular constituents and compartments with the microenvironment. Although it allies with genomic medicine, it is better aligned with integrated medicine. In this perspective, we focus on translational research in cancer care. We expose some intrinsic fallacies in translational research when it relates to the basic principles of the scientific method in the care of patients with genomic medicine versus integrated medicine. We postulate that genomic medicine may be at the root of many failed efforts in drug development and data reproducibility. We propose an alternate heuristic approach that may expedite the development of safe and effective treatments and minimize the generation of unproductive pharmaceutical products and nonreproducible experimental results. Importantly, a heuristic approach emphasizes the role of a pertinent scientific theory and distinguishes therapy development from drug development, such that we discover not only useful drugs but also better ways to use them in order to optimize patient care and maximize clinical outcomes.
format Online
Article
Text
id pubmed-9321703
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93217032022-07-27 Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench Tu, Shi-Ming Singh, Sunny R. Arnaoutakis, Konstantinos Malapati, Sindhu Bhatti, Sajjad A. Joon, Aron Y. Atiq, Omar T. Pisters, Louis L. Cancers (Basel) Perspective SIMPLE SUMMARY: To find the cause of our current failures in drug development and data reproducibility, we may need to search no further than the basic premises of translational research. To enhance cancer research and cancer care, we need to be diligent in the proper application of the scientific method. We postulate that a stem cell theory of cancer embraces genomic medicine and empowers integrated medicine. It alludes to a unified theory of cancer that may advance cancer research by emending translational research and enforcing the scientific method. It may enhance patient care by enabling targeted therapy and employing multimodal therapy, so that we treat the whole cancer and heal the whole patient. ABSTRACT: A stem cell theory of cancer considers genetic makeup in the proper cellular context. It is a unified theory of cancer that unites the genome with the epigenome, links the intracellular with the extracellular, and connects the cellular constituents and compartments with the microenvironment. Although it allies with genomic medicine, it is better aligned with integrated medicine. In this perspective, we focus on translational research in cancer care. We expose some intrinsic fallacies in translational research when it relates to the basic principles of the scientific method in the care of patients with genomic medicine versus integrated medicine. We postulate that genomic medicine may be at the root of many failed efforts in drug development and data reproducibility. We propose an alternate heuristic approach that may expedite the development of safe and effective treatments and minimize the generation of unproductive pharmaceutical products and nonreproducible experimental results. Importantly, a heuristic approach emphasizes the role of a pertinent scientific theory and distinguishes therapy development from drug development, such that we discover not only useful drugs but also better ways to use them in order to optimize patient care and maximize clinical outcomes. MDPI 2022-07-09 /pmc/articles/PMC9321703/ /pubmed/35884406 http://dx.doi.org/10.3390/cancers14143345 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Perspective
Tu, Shi-Ming
Singh, Sunny R.
Arnaoutakis, Konstantinos
Malapati, Sindhu
Bhatti, Sajjad A.
Joon, Aron Y.
Atiq, Omar T.
Pisters, Louis L.
Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
title Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
title_full Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
title_fullStr Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
title_full_unstemmed Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
title_short Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench
title_sort stem cell theory of cancer: implications for translational research from bedside to bench
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321703/
https://www.ncbi.nlm.nih.gov/pubmed/35884406
http://dx.doi.org/10.3390/cancers14143345
work_keys_str_mv AT tushiming stemcelltheoryofcancerimplicationsfortranslationalresearchfrombedsidetobench
AT singhsunnyr stemcelltheoryofcancerimplicationsfortranslationalresearchfrombedsidetobench
AT arnaoutakiskonstantinos stemcelltheoryofcancerimplicationsfortranslationalresearchfrombedsidetobench
AT malapatisindhu stemcelltheoryofcancerimplicationsfortranslationalresearchfrombedsidetobench
AT bhattisajjada stemcelltheoryofcancerimplicationsfortranslationalresearchfrombedsidetobench
AT joonarony stemcelltheoryofcancerimplicationsfortranslationalresearchfrombedsidetobench
AT atiqomart stemcelltheoryofcancerimplicationsfortranslationalresearchfrombedsidetobench
AT pisterslouisl stemcelltheoryofcancerimplicationsfortranslationalresearchfrombedsidetobench